Table 1

Estimated white and black invasive prostate cancer prevalence in the United States on 1 January 1997, according to 0–x cumulative years from diagnosis (Dx) and area (Connecticut, SEER) upon which the estimates were based

0–x Years From DxWhite menBlack men
ConnSEERAbsolute DiffPer cent DiffConnSEERAbsolute DiffPer cent Diff
1161 710141 70620 00414.120 35822 164−1 806−8.9
2322 695276 52146 17416.739 09242 514−3 421−8.8
3478 898408 97869 92017.157 65862 879−5 222−9.1
4628 365552 09876 26713.874 93882 575−7 637−10.2
5784 213703 99680 21711.487 60999 000−11 391−13.0
6893 047823 13569 9128.595 660110 467−14 806−15.5
7964 077902 21061 8666.9101 119117 287−16 168−16.0
81 012 025958 79653 2285.6105 906122 396−16 490−15.6
91 046 0161 004 61741 4004.1108 203126 276−18 073−16.7
101 074 7331 041 49533 2383.2110 168129 712−19 544−17.7
151 153 6981 133 05520 6421.8115 296138 321−23 025−20.0
201 186 8611 166 50820 3521.7117 465141 582−24 117−20.5
221 191 6341 172 25919 3741.7117 693142 185−24 493−20.8
  • SEER: Surveillance, Epidemiology, and End Results. All differences between Connecticut and SEER significant for both white and black men, with p<0.01.